PTEN overexpression improves cisplatin-resistance of human ovarian cancer cells through upregulating KRT10 expression

Biochemical and Biophysical Research Communications

Volumn 444, Issue 2, 2014, Pages 141-146

  Wu, Huijuan ^a   Wang, Ke ^a   Liu, Wenxin ^a   Hao, Quan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Cisplatin; KRT10; Multi drug resistance; Ovarian cancer; PTEN

Indexed keywords

CISPLATIN; KRT10; MULTI-DRUG RESISTANCE; OVARIAN CANCER; PTEN;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATIN-10; OVARIAN NEOPLASMS; PROTEIN BINDING; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UP-REGULATION;

EID: 84894593093     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.01.014     Document Type: Article

References (28)

1. B. Stordal, N. Pavlakis, and R. Davey A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship Cancer Treat. Rev. 33 2007 688 703
2. P.L. Dahia PTEN, a unique tumor suppressor gene Endocr. Relat. Cancer 7 2000 115 129
3. J. Li, C. Yen, and D. Liaw et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1997 1943 1947
4. X. Yan, M. Fraser, and Q. Qiu et al. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner Gynecol. Oncol. 102 2006 348 355
5. M. Singh, P. Chaudhry, and F. Fabi et al. Cisplatin-induced caspase activation mediates PTEN cleavage in ovarian cancer cells: a potential mechanism of chemoresistance BMC Cancer 13 2013 233
6. X. Wan, J. Li, and X. Xie et al. PTEN augments doxorubicin-induced apoptosis in PTEN-null Ishikawa cells Int. J. Gynecol. Cancer 17 2007 808 812
7. J. Li, Y. Zhang, and J. Zhao et al. Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells Mol. Cell. Biochem. 357 2011 31 38
8. T. Schondorf, M. Becker, and U.J. Gohring et al. Interaction of cisplatin, paclitaxel and adriamycin with the tumor suppressor PTEN Anticancer Drugs 12 2001 797 800
9. L.S. Steelman, P.M. Navolanic, and M.L. Sokolosky et al. Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors Oncogene 27 2008 4086 4095
10. H. Wu, Y. Cao, and D. Weng et al. Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms Cancer Lett. 271 2008 260 271
11. S.A. Arafa el, Q. Zhu, and Z.I. Shah et al. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells Mutat. Res. 706 2011 28 35
12. D. Li, Y. Zhang, and Y. Xie et al. Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer Cancer Gene Ther. 20 2013 251 259
13. B.H. Smith, L.S. Gazda, and B.L. Conn et al. Three-dimensional culture of mouse renal carcinoma cells in agarose macrobeads selects for a subpopulation of cells with cancer stem cell or cancer progenitor properties Cancer Res. 71 2011 716 724
14. J. Du, B. Cheng, and X. Zhu et al. Ginsenoside rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects J. Immunol. 187 2011 942 950
15. S. Seton-Rogers Tumour suppressors: PTEN surprise Nat. Rev. Cancer 13 8 2013 520
16. F. Wang, T. Li, and B. Zhang et al. MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN Biochem. Biophys. Res. Commun. 434 2013 688 694
17. X. Li, Z. Yang, and W. Song et al. Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway Int. J. Oncol. 43 3 2013 793 802
18. L.C. Cantley, and B.G. Neel New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway Proc. Natl. Acad. Sci. USA 96 1999 4240 4245
19. G. Cassinelli, V. Zuco, and L. Gatti et al. Targeting the Akt kinase to modulate survival, invasiveness and drug resistance of cancer cells Curr. Med. Chem. 20 2013 1923 1945
20. R. Hou, J. Zhang, and T. Yin et al. Upregulation of PTEN by peroxynitrite contributes to cytokine-induced apoptosis in pancreatic beta-cells Apoptosis 15 2010 877 886
21. L. Han, A.L. Zhang, and P. Xu et al. Combination gene therapy with PTEN and EGFR siRNA suppresses U251 malignant glioma cell growth in vitro and in vivo Med. Oncol. 27 2010 843 852
22. M. Keniry, and R. Parsons The role of PTEN signaling perturbations in cancer and in targeted therapy Oncogene 27 2008 5477 5485
23. J.M. Waters, G.D. Richardson, and C.A. Jahoda Keratin 10 (K10) is expressed suprabasally throughout the limbus of embryonic and neonatal rat corneas, with interrupted expression in the adult limbus Exp. Eye Res. 89 2009 435 438
24. T. Kobayashi, S. Maruyama, and T. Abe et al. Keratin 10-positive orthokeratotic dysplasia: a new leucoplakia-type precancerous entity of the oral mucosa Histopathology 61 2012 910 920
25. J.M. Paramio, M.L. Casanova, and C. Segrelles et al. Modulation of cell proliferation by cytokeratins K10 and K16 Mol. Cell. Biol. 19 1999 3086 3094
26. J. Reichelt, G. Furstenberger, and T.M. Magin Loss of keratin 10 leads to mitogen-activated protein kinase (MAPK) activation, increased keratinocyte turnover, and decreased tumor formation in mice J. Invest. Dermatol. 123 2004 973 981
27. T.M. Magin, P. Vijayaraj, and R.E. Leube Structural and regulatory functions of keratins Exp. Cell Res. 313 2007 2021 2032
28. J. Reichelt, B. Breiden, and K. Sandhoff et al. Loss of keratin 10 is accompanied by increased sebocyte proliferation and differentiation Eur. J. Cell Biol. 83 2004 747 759